Digoxin Quo Vadis?

被引：15

作者：

Cleland, John G. F. ^{[1
]}

Cullington, Damien ^{[1
]}

机构：

[1] Univ Hull, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Cottingham, England

来源：

CIRCULATION-HEART FAILURE | 2009年 / 2卷 / 02期

关键词：

Editorials; digoxin; CHRONIC HEART-FAILURE; CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSFUNCTION; ATRIAL-FIBRILLATION; RANDOMIZED-TRIAL; CLINICAL-OUTCOMES; EUROPEAN TRIAL; BETA-BLOCKER; GISSI-HF; MORTALITY;

D O I：

10.1161/CIRCHEARTFAILURE.109.859322

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 85

页数：5

共 56 条

[41] WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART-FAILURE TREATED WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].

PACKER, M ;

GHEORGHIADE, M ;

YOUNG, JB ;

COSTANTINI, PJ ;

ADAMS, KF ;

CODY, RJ ;

SMITH, LK ;

VANVOORHEES, L ;

GOURLEY, LA ;

JOLLY, MK .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (01) :1-7

[42] Effect of carvedilol on survival in severe chronic heart failure. [J].

Packer, M ;

Coats, AJS ;

Fowler, MB ;

Katus, HA ;

Krum, H ;

Mohacsi, P ;

Rouleau, JL ;

Tendera, M ;

Castaigne, A ;

Roecker, EB ;

Schultz, MK ;

DeMets, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1651-1658

[43] The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].

Packer, M ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Fowler, MB ;

Gilbert, EM ;

Shusterman, NH .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355

[44]

Perry G, 1997, NEW ENGL J MED, V336, P525

[45] Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II [J].

Pitt, B ;

Poole-Wilson, PA ;

Segal, R ;

Martinez, FA ;

Dickstein, K ;

Camm, AJ ;

Konstam, MA ;

Riegger, G ;

Klinger, GH ;

Neaton, J ;

Sharma, D ;

Thiyagarajan, B .

LANCET, 2000, 355 (9215) :1582-1587

[46] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[47] Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial [J].

Poole-Wilson, PA ;

Swedberg, K ;

Cleland, JGF ;

Di Lenarda, A ;

Hanrath, P ;

Komajda, M ;

Lubsen, J ;

Lutiger, E ;

Metra, M ;

Remme, WJ ;

Torp-Pedersen, C ;

Scherhag, A ;

Skene, A .

LANCET, 2003, 362 (9377) :7-13

[48] Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure [J].

Raphael, C. E. ;

Whinnett, Z. I. ;

Davies, J. E. ;

Fontana, M. ;

Ferenczi, E. A. ;

Manisty, C. H. ;

Mayet, J. ;

Francis, D. P. .

HEART, 2009, 95 (01) :56-62

[49] Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: The DIG study [J].

Rich, MW ;

McSherry, F ;

Williford, WO ;

Yusuf, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :806-813

[50] Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with betablockers: Results from COMET [J].

Swedberg, K ;

Olsson, LG ;

Charlesworth, A ;

Cleland, J ;

Hanrath, P ;

Komajda, M ;

Metra, M ;

Torp-Pedersen, C ;

Poole-Wilson, P .

EUROPEAN HEART JOURNAL, 2005, 26 (13) :1303-1308

← 1 2 3 4 5 6 →